World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
36643
World Ranking
9993
National Ranking
141

Dolors Colomer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dolors Colomer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 453 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dolors Colomer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dolors Colomer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dolors Colomer is affiliated with the University of Barcelona in Spain. Their research primarily spans the field of Medicine, with a focus on several subfields including Genetics, Pathology and Forensic Medicine, Immunology, Molecular Biology, and Oncology.

The scientist's work covers various main topics such as:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Frequent publication venues for Dolors Colomer include:

  • Blood
  • Leukemia
  • HemaSphere
  • Blood Advances
  • Cancers

Some of the recent papers where Dolors Colomer is a co-author include:

  • Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes (2020, Blood)
  • Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation (2021, Nature Communications)
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia (2022, Nature Medicine)
  • Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity (2021, Immunity)
  • An atlas of cells in the human tonsil (2024, Immunity)

Frequent co-authors associated with Dolors Colomer include:

  • Elías Campo
  • Mònica López-Guerra
  • Sílvia Beà
  • Ferran Nadeu
  • José I. Martín-Subero

Best Publications

  • Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Mario F Fraga;Esteban Ballestar;Ana Villar-Garea;Manuel Boix-Chornet

  • Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde

  • ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

    Marta Crespo;Francesc Bosch;Neus Villamor;Beatriz Bellosillo

  • Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

    Víctor Quesada;Laura Conde;Neus Villamor;Gonzalo R Ordóñez

  • Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Xose S. Puente;Silvia Beà;Rafael Valdés-Mas;Neus Villamor

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas.

    Sílvia Beà;Frederic Tort;Magda Pinyol;Xavier Puig

  • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Marta Kulis;Simon Heath;Marina Bibikova;Ana C Queirós

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

    Pedro Jares;Dolors Colomer;Elias Campo

  • Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

    Lluı́s Colomo;Armando López-Guillermo;Armando López-Guillermo;Marı́a Perales;Marı́a Perales;Susana Rives;Susana Rives

  • A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

    Miguel A. Sanz;Guillermo Martı́n;Consuelo Rayón;Jordi Esteve

  • The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

    Patricia Pérez-Galán;Gaël Roué;Neus Villamor;Emili Montserrat

  • Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Sílvia Beà;Rafael Valdés-Mas;Alba Navarro;Itziar Salaverria

  • Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

    Verònica Fernàndez;Olga Salamero;Blanca Espinet;Francesc Solé

  • International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

    A C Rawstron;N Villamor;M Ritgen;S Böttcher

  • Molecular pathogenesis of mantle cell lymphoma

    Pedro Jares;Dolors Colomer;Elias Campo

  • SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

    Ana Mozos;Cristina Royo;Elena Hartmann;Daphne De Jong

  • Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

    Elisa Rumi;Daniela Pietra;Cristiana Pascutto;Paola Guglielmelli

  • Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

    Armando López-Guillermo;Luis Colomo;Mónica Jiménez;Francesc Bosch

Frequent Co-Authors

Elias Campo
Elias Campo University of Barcelona
Neus Villamor
Neus Villamor University of Barcelona
Emili Montserrat
Emili Montserrat University of Barcelona
Armando López-Guillermo
Armando López-Guillermo University of Barcelona
Sílvia Beà
Sílvia Beà University of Barcelona
Francisco Cervantes
Francisco Cervantes University of Barcelona
Itziar Salaverria
Itziar Salaverria University of Barcelona
Xose S. Puente
Xose S. Puente University of Oviedo
Marcos González
Marcos González University of Salamanca
Carlos López-Otín
Carlos López-Otín University of Oviedo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens the door to various online degree programs and specialized pathways. If you’re seeking healthcare leadership, consider cahme accredited mha online programs, which ensure your master’s in health administration meets rigorous industry standards.

Registered nurses looking to advance can now find flexible study options. For instance, there are rn to bsn without clinicals, making it easier for working nurses to earn their bachelor’s degree fully online without in-person clinical requirements.

For nurses aiming for top clinical qualifications, online Doctor of Nursing Practice programs can offer both convenience and speed. Some options focus on efficiency, like the shortest msn to dnp program, helping you progress quickly from a master’s to doctorate level. Others are designed for accessibility and ease, as seen in the easiest online dnp programs which prioritize user-friendly curricula and flexible scheduling.

Online medical and healthcare degrees allow you to tailor your education to fit your career goals, time frame, and lifestyle, making the pursuit of advanced roles in healthcare more accessible than ever.

Best Scientists Citing Dolors Colomer

Trending Scientists

Recently Published Articles